These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 30968734
21. Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry. Papp V, Buron MD, Siersma V, Rasmussen PV, Illes Z, Kant M, Hilt C, Mezei Z, Roshanisefat H, Sejbæk T, Weglewski A, van Wingerden J, Geertsen SS, Bramow S, Sellebjerg F, Magyari M. PLoS One; 2021; 16(5):e0250820. PubMed ID: 34003862 [Abstract] [Full Text] [Related]
25. The pill times 2: what every woman with multiple sclerosis should know. Henson LJ, Cavalier S, Langer-Gould AM. Neurology; 2014 Oct 28; 83(18):1685. PubMed ID: 25349277 [No Abstract] [Full Text] [Related]
26. Rebound syndrome in two cases of MS patients after teriflunomide cessation. Labauge P, Ayrignac X, Prin P, Charif M, Carra-Dalliere C. Acta Neurol Belg; 2022 Oct 28; 122(5):1381-1384. PubMed ID: 35802339 [No Abstract] [Full Text] [Related]
29. Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Karlsson G, Francis G, Koren G, Heining P, Zhang X, Cohen JA, Kappos L, Collins W. Neurology; 2014 Feb 25; 82(8):674-80. PubMed ID: 24463630 [Abstract] [Full Text] [Related]
32. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. Coppola D, Russo LJ, Kwarta RF, Varughese R, Schmider J. Drug Saf; 2007 Feb 25; 30(3):247-64. PubMed ID: 17343431 [Abstract] [Full Text] [Related]
33. Chronic necrotizing aspergillosis: A new risk with teriflunomide in multiple sclerosis patients? Pourcher V, Yeung J, Le Pimpec-Barthes F, Maillart E, Gibault L, Boussouar S. Rev Neurol (Paris); 2022 Mar 25; 178(3):266-267. PubMed ID: 34579947 [No Abstract] [Full Text] [Related]
34. Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial. Miller AE, Wolinsky JS, Kappos L, Comi G, Freedman MS, Olsson TP, Bauer D, Benamor M, Truffinet P, O'Connor PW, TOPIC Study Group. Lancet Neurol; 2014 Oct 25; 13(10):977-86. PubMed ID: 25192851 [Abstract] [Full Text] [Related]
36. Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data. Hoeltzenbein M, Beck E, Rajwanshi R, Gøtestam Skorpen C, Berber E, Schaefer C, Østensen M. Semin Arthritis Rheum; 2016 Oct 25; 46(2):238-245. PubMed ID: 27346577 [Abstract] [Full Text] [Related]